Saratan Therapeutics' Series A Round

Saratan Therapeutics raised a round of funding on August 18, 2009. Investors include Trans Tasman Commercialisation Fund.

Saratan's current drug development programme focuses on novel therapies for cancer treatment.…

Articles about Saratan Therapeutics' Series A Round: